Projects per year
Fingerprint Dive into the research topics where Esteban Celis is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 16 Similar Profiles
T-Lymphocytes
Medicine & Life Sciences
Peptides
Medicine & Life Sciences
Epitopes
Medicine & Life Sciences
Neoplasms
Medicine & Life Sciences
Cytotoxic T-Lymphocytes
Medicine & Life Sciences
Subunit Vaccines
Medicine & Life Sciences
Immunotherapy
Medicine & Life Sciences
Antigens
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects 1992 2017
- 8 Finished
Interferon-gamma limits the effectiveness of peptide vaccines for cancer
2/28/12 → 12/31/17
Project: Research project
Subunit Vaccines
Interferon-gamma
T-Lymphocytes
Neoplasms
Immunotherapy
Subunit Vaccines
Melanoma
Vaccines
T-Lymphocytes
Neoplasms
Subunit Vaccines
Neoplasms
Cytotoxic T-Lymphocytes
Helper-Inducer T-Lymphocytes
T-Lymphocyte Epitopes
SPORE in Prostate Cancer
Young, C., Fatemi, M., Morris, J. C., Thibodeau, S. N., Vile, R., Vasmatzis, G., Jenkins, R. B., Bergstralh, E. J., Cheville, J., Klee, G., Tindall, D. J., Davis, B., Sargent, D., Layton, D., Vuk-Pavlovic, S. & Celis, E.
8/31/01 → 8/31/13
Project: Research project
Prostatic Neoplasms
Cytotoxic T-Lymphocytes
Helper-Inducer T-Lymphocytes
Neoplasms
Therapeutics
Prostatic Neoplasms
Cytotoxic T-Lymphocytes
Major Histocompatibility Complex
T-Lymphocyte Epitopes
Antigens
Research Output 1973 2019
PD-L1-specific helper T-cells exhibit effective antitumor responses: New strategy of cancer immunotherapy targeting PD-L1 in head and neck squamous cell carcinoma
Hirata-Nozaki, Y., Ohkuri, T., Ohara, K., Kumai, T., Nagata, M., Harabuchi, S., Kosaka, A., Nagato, T., Ishibashi, K., Oikawa, K., Aoki, N., Ohara, M., Harabuchi, Y., Uno, Y., Takei, H., Celis, E. & Kobayashi, H., Jun 20 2019, In : Journal of Translational Medicine. 17, 1, 207.Research output: Contribution to journal › Article
Open Access
Th1 Cells
T-cells
Immunotherapy
Ligands
Helper-Inducer T-Lymphocytes
Primary tumor-induced immunity eradicates disseminated tumor cells in syngeneic mouse model
Piranlioglu, R., Lee, E. M., Ouzounova, M., Bollag, R. J., Vinyard, A., Arbab, A. S., Marasco, D., Guzel, M., Cowell, J. K., Thangaraju, M., Chadli, A., Hassan, K. A., Wicha, M. S., Celis, E. & Korkaya, H., Dec 1 2019, In : Nature Communications. 10, 1, 1430.Research output: Contribution to journal › Article
immunity
mice
Tumors
Immunity
tumors
1
Citation
(Scopus)
The route of administration dictates the immunogenicity of peptide-based cancer vaccines in mice
Sultan, H., Kumai, T., Nagato, T., Wu, J., Salazar, A. M. & Celis, E., Mar 13 2019, In : Cancer Immunology, Immunotherapy. 68, 3, p. 455-466 12 p.Research output: Contribution to journal › Article
Cancer Vaccines
Subunit Vaccines
Cytotoxic T-Lymphocytes
Peptides
Vaccines
4
Citations
(Scopus)
An osteopontin/CD44 immune checkpoint controls CD8+ T cell activation and tumor immune evasion
Klement, J. D., Paschall, A. V., Redd, P. S., Ibrahim, M. L., Lu, C., Yang, D., Celis, E., Abrams, S. I., Ozato, K. & Liu, K., Dec 3 2018, In : Journal of Clinical Investigation. 128, 12, p. 5549-5560 12 p.Research output: Contribution to journal › Article
Tumor Escape
Osteopontin
T-Lymphocytes
Immunotherapy
Colon
1
Citation
(Scopus)
H3K4me3 mediates the NF-κB p50 homodimer binding to the pdcd1 promoter to activate PD-1 transcription in T cells
Redd, P. S., Lu, C., Klement, J. D., Ibrahim, M. L., Zhou, G., Kumai, T., Celis, E. & Liu, K., Sep 2 2018, In : OncoImmunology. 7, 9, e1483302.Research output: Contribution to journal › Article
T-Lymphocytes
CD8 Antigens
Immunologic Monitoring
CD4 Antigens
T-Cell Antigen Receptor